Mason Joe's Album: Wall Photos
The market for
single-use bioreactors is growing at an annualized rate of over 18%, claims
Roots Analysis
Report Keywords- Single-Use
Bioreactors, Bioreactor, Roots Analysis, Biotech, Analysis
Single-use
bioreactors are a revolutionary product of the process optimization efforts of
drug manufacturers, offering a highly flexible approach to rapidly produce
multiple drugs, while notably reducing downtime between batches and operational
costs
Roots Analysis has announced the addition of “Single-Use
Bioreactors Market, 2021-2030” report to its list of offerings.
Traditionally, stainless
steel bioreactors were the preferred choice for production of biologics;
however, over the past couple of decades, biopharmaceutical manufacturing has
gradually witnessed a shift towards the use of single-use technologies. Apart
from low contamination risk and better product yield, single-use bioreactors
are easy-to-install and have a much smaller footprint, compared to the
traditional stainless steel systems.
To order this 267
page report, which features 110 figures and 160 tables, please visit the –
https://www.rootsanalysis.com/reports/single-use-bioreactors-market/request-sample.html
Key Market Insights
160 single-use bioreactors are currently available / under
development for different scales of operation
It is worth noting that most of the single-use bioreactors (49%) are
stirred tank bioreactors, followed by pneumatically mixed bioreactors (9%). It is worth highlighting that nearly 70% of single-use bioreactors
support laboratory scale operations.
Majority (40%) of the single-use bioreactors are intended
for mammalian cell culture
Presently, several bioreactors are also being used to culture
appropriate host cells for studying the pathogenesis of the novel coronavirus. Other
popular application areas for single-use bioreactors include stem cell research
(47%), and cancer research (20%).
Close to 40 players are driving the activity within the single-use
bioreactors industry
Majority
(47%) of the initiatives in this domain are led by small-sized firms, followed
by mid-sized (24%) and large players (29%). Further, around 60% of the firms engaged in providing single-use
bioreactors were established post 2000.
Partnership activity in this field has grown at
a CAGR of ~16%, between 2015 and 2020
Nearly 45% of the reported deals were
established after 2015, with the maximum activity being reported in 2017. Majority
of the partnerships inked within this domain were product / technology
integration agreements (30%), followed by full business acquisitions (22%) and product
/ technology development agreements (15%).
2,800+ patents that have been filed / granted
for single-use bioreactors, till 2020
Based on the
intellectual property distribution across the world, R&D activity related
to single-use bioreactors is largely concentrated in the US (around 47%).
Majority of the patents in this field were filed by industry players (94%).
North America and Europe are anticipated to capture over
33.5% of the market share by 2030
The market in Asia-Pacific are anticipated to grow at a
relatively faster rate (over 20%). In 2030, mammalian cell cultures
are likely to capture the largest market share (36%) in terms of revenues from
product sales, followed by viral cell cultures (20%), microbial cell cultures
(15%) and insect cell cultures (11%).
Key Questions Answered
§
Who are the leading
manufacturers engaged in the development of single-use bioreactors?
§
What are the
different applications of single-use bioreactors?
§
Which partnership models
are commonly adopted by stakeholders in this industry?
§
Which features of
single-use bioreactors are most important to end-users?
§
What are the
challenges currently faced by stakeholders in this industry?
§
What are the key
factors that are likely to influence the evolution of this market?
§
How has the COVID-19
pandemic impacted the single-use bioreactors market?
§
How is the current
and future opportunity likely to be distributed across key market segments?
§
What are the
anticipated future trends related to single-use bioreactors?
The USD 6.6 billion (by 2030) financial
opportunity within the single-use bioreactors market has been analyzed across
the following segments:
§
Type of Cell Culture
§
Bacterial Cell
Cultures
§
Insect Cell Cultures
§
Mammalian Cell
Cultures
§
Microbial Cell
Cultures
§
Plant Cell Cultures
§
Viral Cell Cultures
§
Other Cell Cultures
§
Type of Molecule
§
Cell Therapies
§
Gene Therapies
§
Monoclonal Antibodies
§
Recombinant Proteins
§
Stem Cell Therapies
§
Vaccines
§
Other Molecules
§
Application Area
§
Cancer Research
§
Drug Discovery and
Toxicity Testing
§
Regenerative Medicine
and Tissue Engineering
§
Stem Cell Research
§
Other Application
Areas
§
Scale of Operation
§
Small Scale
Operations
§
Large Scale
Operations
§
Purpose
§
Research and Development
§
Biopharmaceutical
Manufacturing
§
End-User
§
Biopharmaceutical /
Pharmaceutical Industries
§
Academic / Research
Institutes
§
Key Geographical
Regions
§
North America
§
Europe
§
Asia-Pacific
§
Latin America (LATM)
§
Middle East and North
Africa (MENA)
§
Rest of the World
(RoW)
The
report features inputs from eminent industry stakeholders, according to whom, the
US is likely to dominate this market, despite the fact that the country is
currently facing several political challenges, as well as problems related to
the COVID-19 pandemic. The report includes detailed transcripts of discussions
held with the following industry experts:
§ Per Stobbe (Chief Executive Officer, Marketing, Technical Support,
CerCell)
§ Torsten Due Bryld (Chief Commercial Officer, CelVivo)
The research includes detailed profiles of key
players (listed below) engaged in the development of single-use
bioreactors; each profile features an overview of the developer, details
related to its product portfolio, and recent developments, and an informed
future outlook:
§
Celartia
§
Cell Culture Company
§
Cellexus
§
CerCell
§
CESCO Bioengineering
§
Cytiva
§
Eppendorf
§
Merck Millipore
§
Pall Corporation
§
PBS Biotech
§
PerfuseCell
§
Pierre Guerin
§
ProlifeCell
§
Sartorius Stedim
Biotech
§
Solaris Biotech
§
Synthecon
§
Thermo Fisher
Scientific
For additional details, please visit
https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html
You may also be interested in the following
titles:
1. 3D Cell Culture Market
by Scaffold Format Market, (3rd Edition), 2020-2030
2. Cell Line Development
and Characterization Services Market, (2nd Edition), 2020-2030
3. Automated
and Closed Cell Therapy Processing Systems Market, 2020-2030
About Roots
Analysis
Roots Analysis is
one of the fastest growing market research companies, sharing fresh and
independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter
- https://twitter.com/RootsAnalysis
single-use bioreactors is growing at an annualized rate of over 18%, claims
Roots Analysis
Report Keywords- Single-Use
Bioreactors, Bioreactor, Roots Analysis, Biotech, Analysis
Single-use
bioreactors are a revolutionary product of the process optimization efforts of
drug manufacturers, offering a highly flexible approach to rapidly produce
multiple drugs, while notably reducing downtime between batches and operational
costs
Roots Analysis has announced the addition of “Single-Use
Bioreactors Market, 2021-2030” report to its list of offerings.
Traditionally, stainless
steel bioreactors were the preferred choice for production of biologics;
however, over the past couple of decades, biopharmaceutical manufacturing has
gradually witnessed a shift towards the use of single-use technologies. Apart
from low contamination risk and better product yield, single-use bioreactors
are easy-to-install and have a much smaller footprint, compared to the
traditional stainless steel systems.
To order this 267
page report, which features 110 figures and 160 tables, please visit the –
https://www.rootsanalysis.com/reports/single-use-bioreactors-market/request-sample.html
Key Market Insights
160 single-use bioreactors are currently available / under
development for different scales of operation
It is worth noting that most of the single-use bioreactors (49%) are
stirred tank bioreactors, followed by pneumatically mixed bioreactors (9%). It is worth highlighting that nearly 70% of single-use bioreactors
support laboratory scale operations.
Majority (40%) of the single-use bioreactors are intended
for mammalian cell culture
Presently, several bioreactors are also being used to culture
appropriate host cells for studying the pathogenesis of the novel coronavirus. Other
popular application areas for single-use bioreactors include stem cell research
(47%), and cancer research (20%).
Close to 40 players are driving the activity within the single-use
bioreactors industry
Majority
(47%) of the initiatives in this domain are led by small-sized firms, followed
by mid-sized (24%) and large players (29%). Further, around 60% of the firms engaged in providing single-use
bioreactors were established post 2000.
Partnership activity in this field has grown at
a CAGR of ~16%, between 2015 and 2020
Nearly 45% of the reported deals were
established after 2015, with the maximum activity being reported in 2017. Majority
of the partnerships inked within this domain were product / technology
integration agreements (30%), followed by full business acquisitions (22%) and product
/ technology development agreements (15%).
2,800+ patents that have been filed / granted
for single-use bioreactors, till 2020
Based on the
intellectual property distribution across the world, R&D activity related
to single-use bioreactors is largely concentrated in the US (around 47%).
Majority of the patents in this field were filed by industry players (94%).
North America and Europe are anticipated to capture over
33.5% of the market share by 2030
The market in Asia-Pacific are anticipated to grow at a
relatively faster rate (over 20%). In 2030, mammalian cell cultures
are likely to capture the largest market share (36%) in terms of revenues from
product sales, followed by viral cell cultures (20%), microbial cell cultures
(15%) and insect cell cultures (11%).
Key Questions Answered
§
Who are the leading
manufacturers engaged in the development of single-use bioreactors?
§
What are the
different applications of single-use bioreactors?
§
Which partnership models
are commonly adopted by stakeholders in this industry?
§
Which features of
single-use bioreactors are most important to end-users?
§
What are the
challenges currently faced by stakeholders in this industry?
§
What are the key
factors that are likely to influence the evolution of this market?
§
How has the COVID-19
pandemic impacted the single-use bioreactors market?
§
How is the current
and future opportunity likely to be distributed across key market segments?
§
What are the
anticipated future trends related to single-use bioreactors?
The USD 6.6 billion (by 2030) financial
opportunity within the single-use bioreactors market has been analyzed across
the following segments:
§
Type of Cell Culture
§
Bacterial Cell
Cultures
§
Insect Cell Cultures
§
Mammalian Cell
Cultures
§
Microbial Cell
Cultures
§
Plant Cell Cultures
§
Viral Cell Cultures
§
Other Cell Cultures
§
Type of Molecule
§
Cell Therapies
§
Gene Therapies
§
Monoclonal Antibodies
§
Recombinant Proteins
§
Stem Cell Therapies
§
Vaccines
§
Other Molecules
§
Application Area
§
Cancer Research
§
Drug Discovery and
Toxicity Testing
§
Regenerative Medicine
and Tissue Engineering
§
Stem Cell Research
§
Other Application
Areas
§
Scale of Operation
§
Small Scale
Operations
§
Large Scale
Operations
§
Purpose
§
Research and Development
§
Biopharmaceutical
Manufacturing
§
End-User
§
Biopharmaceutical /
Pharmaceutical Industries
§
Academic / Research
Institutes
§
Key Geographical
Regions
§
North America
§
Europe
§
Asia-Pacific
§
Latin America (LATM)
§
Middle East and North
Africa (MENA)
§
Rest of the World
(RoW)
The
report features inputs from eminent industry stakeholders, according to whom, the
US is likely to dominate this market, despite the fact that the country is
currently facing several political challenges, as well as problems related to
the COVID-19 pandemic. The report includes detailed transcripts of discussions
held with the following industry experts:
§ Per Stobbe (Chief Executive Officer, Marketing, Technical Support,
CerCell)
§ Torsten Due Bryld (Chief Commercial Officer, CelVivo)
The research includes detailed profiles of key
players (listed below) engaged in the development of single-use
bioreactors; each profile features an overview of the developer, details
related to its product portfolio, and recent developments, and an informed
future outlook:
§
Celartia
§
Cell Culture Company
§
Cellexus
§
CerCell
§
CESCO Bioengineering
§
Cytiva
§
Eppendorf
§
Merck Millipore
§
Pall Corporation
§
PBS Biotech
§
PerfuseCell
§
Pierre Guerin
§
ProlifeCell
§
Sartorius Stedim
Biotech
§
Solaris Biotech
§
Synthecon
§
Thermo Fisher
Scientific
For additional details, please visit
https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html
You may also be interested in the following
titles:
1. 3D Cell Culture Market
by Scaffold Format Market, (3rd Edition), 2020-2030
2. Cell Line Development
and Characterization Services Market, (2nd Edition), 2020-2030
3. Automated
and Closed Cell Therapy Processing Systems Market, 2020-2030
About Roots
Analysis
Roots Analysis is
one of the fastest growing market research companies, sharing fresh and
independent perspectives in the bio-pharmaceutical industry. The in-depth
research, analysis and insights are driven by an experienced leadership team
which has gained many years of significant experience in this sector. If you’d
like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private
Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
- https://twitter.com/RootsAnalysis